Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

This publication has 31 references indexed in Scilit:

• The postchemotherapy PSA surge syndrome
  Annals of Oncology, 2008
• Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience
  European Urology, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Weekly Docetaxel and Prednisolone versus Prednisolone Alone in Androgen-Independent Prostate Cancer: A Randomized Phase II Study
  European Urology, 2007
• A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis
  Clinical Cancer Research, 2007
• Comprehensive Geriatric assessment and its clinical impact in oncology
  European Journal Of Cancer, 2007
• Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)
  Annals of Oncology, 2005
• Comparison of Pharmacokinetics and Pharmacodynamics of Docetaxel and Cisplatin in Elderly and Non-Elderly Patients: Why Is Toxicity Increased in Elderly Patients?
  Journal of Clinical Oncology, 2004
• Taxanes in elderly breast cancer patients
  Cancer Treatment Reviews, 2004
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000